Introduction
Neoplasias of the thyroid are the most common malignancy of the endocrine system (Parkin et al., 2005) . The majority of thyroid cancers (95%) are derived from follicular cells and are broadly divided into well-differentiated, poorly differentiated (PDTCs) and undifferentiated anaplastic thyroid carcinomas (ATCs). The most common thyroid cancers are welldifferentiated papillary (PTC) and follicular (FTC) thyroid carcinomas, which typically have an excellent prognosis. In contrast, ATCs are highly aggressive and rapidly invade the adjacent tissue. In agreement with their dramatic presentation, the survival rate of ATCs is less than 17% and no effective treatment is available so far (Kondo et al., 2006) .
As observed for various neoplasias, thyroid carcinomas of follicular origin are distinguished by aberrant microRNA expression (He et al., 2005; Pallante et al., 2006; Weber et al., 2006; Visone et al., 2007; Nikiforova et al., 2008; Schwertheim et al., 2009) . Recent studies revealed deregulation of 31 microRNAs in ATCs compared with normal thyroid (Supplementary Table 1 ). The in vitro validation of four microRNAs that were decreased in ATCs showed a cell growth suppressive function of miR-26a and miR-125b in ATCderived cells (Visone et al., 2007) . However, whether altered microRNA expression also mediates de-/transdifferentiation and invasion of ATCs was not addressed.
To identify microRNAs potentially involved in directing these events, miR levels of three primary ATC samples were analyzed in comparison with three normal thyroid samples using microarray analyses. In consensus with previous studies, more downregulated (62) than upregulated (21) microRNAs were identified in ATCs (Table 1 ; the complete array data are shown in Supplementary Table 2 ). With the exception of let-7f and miR-135-2, the observed microRNA signatures covered more microRNAs but essentially revealed similar patterns as previously reported (Visone et al., 2007; Supplementary Table 1) . Surprisingly, only upregulated expression of miR-221 or -222 was confirmed in comparison with the studies presented by Nikiforova et al. (2008) . Levels of these microRNAs were increased in PTCs and FTCs as well (Pallante et al., 2006; Visone et al., 2007; Nikiforova et al., 2008) . This suggests that the postulated proproliferative role of these 'onco-miRs' promotes tumor growth in all thyroid carcinomas of follicular origin, presumably by miR-221 or 222-directed downregulation of p27 as previously proposed (Resnick et al., 1998; Mercatelli et al., 2008; Kim et al., 2009) . In contrast to upregulated microRNAs, the decreased miR population in ATCs covers 12 microRNA families and is mainly clustered in 12 transcription units. This and the finding that approximately three times more microRNAs were down-than upregulated in ATCs (Table 1) suggested that the selective decrease in microRNAs: (1) distinguishes ATCs from FTCs and PTCs; (2) promotes de-/transdifferentiation and the invasive potential of ATCs.
To validate decreased microRNA expression in thyroid carcinomas of follicular origin, the abundance of miRs, determined as severely reduced in ATCs (200 family, 30d/e, 26a/b and let7d/g), was analyzed by quantitative reverse transcription-polymerase chain reaction using TaqMan probes (Figures 1a-d) . In ATCs, the most severe decrease (at least 10-fold) was observed for the miR-200 family. In contrast, its expression remained essentially unaffected in PTCs and FTCs or Abbreviations: ATC, anaplastic thyroid carcinoma; NT, normal thyroid. MicroRNA abundance in ATCs vs NT was determined by pair-wise microarray analyses of three ATC and NT (normal thyroid) samples using the PIQOR miRXplore service (Milteny Inc., Bergisch Gladbach, Germany). The fold change of each ATC/NT pair represents the microRNA abundance in ATCs relative to NT. The average fold change was calculated from at least two analyzed pairs with fold change (up or down) of at least twofold. Genomic clustering of microRNAs is indicated by frames and microRNA families are highlighted by distinct colors. MicroRNAs affected in only one analyzed ATC/NT pair are not shown. *Three pairs with the same trend, but just two upon threshold. miRs deregulated with the same trend in all three analyzed pairs, with one-pair analysis revealing a fold change o2. **Two pairs upon threshold, three pairs not detected, showing lack of miR detection in one-pair analysis. ***Two pairs upon threshold, third pair shows the opposite trend.
was even slightly increased compared with normal thyroid (Figure 1a) . The expression of all five miR-30 members was significantly lower in ATCs than in normal thyroid, PTC and FTC, whereas let-7d/g and miR-26a/b expression was reduced approximately twofold in all carcinomas (Figures 1b-d) . These findings indicated that downregulation of the miR-200 and miR-30 families unambiguously distinguished ATCs from PTCs or FTCs. Hence, we hypothesized that reduced expression of these microRNAs could promote the de-/ transdifferentiation and invasive potential of ATCs.
The miR-200 family was recently identified as a suppressor of EMT (epithelial-mesenchymal transition) and thus suggested to interfere with metastasis by sustaining an epithelial character of tissues Park et al., 2008) . This role was shown to rely on miR-200-controlled expression of essential EMT/mesenchymal-epithelial transition (MET) modulators, namely, ZEB1/2, SNAI2 and TGFb2 (Burk et al., 2008; Gregory et al., 2008; Park et al., 2008) . Thus, the observed decrease of this microRNA family indicated a correlation of altered microRNA signatures with EMT and thus the invasive potential of ATCs, as previously suggested for breast cancers . The miR-30 family was found to be decreased in metastatic hepatocellular carcinomas and its reduced expression was previously reported for ATCs (Visone et al., 2007; Budhu et al., 2008) . However, in vitro studies excluded a function of the miR-30 family in growth control, whereas a potential role in controlling EMT/MET or cell invasion was not analyzed.
A putative role of both microRNA families in directing EMT/MET and the invasive potential of ATCs was analyzed in vitro. As expected, overexpression of an miR-200 family pool (141, 200a and 200c) induced an epithelial morphology 72 h after transfection in ATCderived cells (Figure 2a ). This was accompanied by a severe increase in E-cadherin and a decrease in vimentin protein and mRNA levels (Figures 2b and c) . Transfection of synthetic miR-30d/e led to changes in cell morphology as well and was associated with reduced vimentin expression (Figures 2a-c) . However, morphological changes were less significant compared with the overexpression of the miR-200 pool. In agreement, ZEB1/2 protein and mRNA levels were not or, in the case of ZEB2, only modestly affected upon the transfection of miR-30d/e. E-cadherin expression was restored effectively by the miR-200 but not by the miR-30 pool, whereas vimentin expression was modulated by both miR families (Figures 2b and c) . Hence, the miR-200 family seemed to be an effective regulator of E-cadherin and vimentin expression, whereas the miR-30 family only modulated vimentin expression. Notably, elevated vimentin expression was shown to be a hallmark of invasive PTCs in which the protein was suggested to promote mesenchymal morphology and invasion (Vasko et al., 2007) . Thus, the reduced expression of both microRNA families in ATCs presumably promoted EMT and invasiveness. This conclusion was further supported by the loss of Ecadherin and a significant upregulation of vimentin in all analyzed primary ATC samples (Figure 2d ). In contrast, expression of E-cadherin remained unaffected in all analyzed PTCs or FTCs, whereas vimentin expression was modestly upregulated in all PTCs and four FTCs. Increased expression of vimentin in PTCs or FTCs could indicate an elevated invasive potential, as previously proposed (Vasko et al., 2007) . However, a severe decrease in E-cadherin expression was only observed in ATCs, confirming previous findings (Brabant et al., 1993; Rocha et al., 2003) . This suggested the loss of E-cadherin as a crucial event in determining the degree of dedifferentiation in anaplastic thyroid carcinomas. Consistently, ZEB1 and/or ZEB2 expression was significantly elevated in all analyzed ATCs and remained unaffected in PTCs and FTCs (Figures 2d  and e) . These findings indicated that the decrease in miR-200/30 levels promotes EMT by elevated ZEB expression. The latter could induce a severe reduction in E-cadherin levels, as previously shown in vitro Park et al., 2008) .
The role of miR-200 and -30 families in invasion was analyzed in ATC-derived cells. Transfection of both microRNA pools resulted in decreased invasion in vitro (Figure 2f ). This was in agreement with the observed induction of MET and associated changes in gene expression providing further evidence for vimentin as a marker of invasive thyroid carcinomas (Vasko et al., 2007) . Therefore, both miR families were classified as 'antiinvasive miRs'.
Recent analyses revealed that TGFb negatively regulates expression of the miR-200 family and thereby promotes ZEB expression leading to EMT in vitro . Vice versa, overexpression of this microRNA family in mesenchymal cells promoted MET (Park et al., 2008) . The crosstalk of miR-200 and ZEBs is controlled by a feedback mechanism involving miR-200-mediated degradation of ZEB mRNAs and repression of miR-200 transcription by ZEBs (Bracken et al., 2008; Burk et al., 2008) . Next to ZEBs, additional factors involved in TGFb signaling and the modulation of EMT/MET were identified as miR-200 targets: TGFb2 and SNAI2 (Burk et al., 2008) . TGFb signaling as a modulator of thyroid carcinoma invasion was supported by elevated TGFb and vimentin levels at the invasive front of invasive PTCs (Vasko et al., 2007) . Together, this suggested that TGFb-mediated changes in microRNA levels induce altered gene expression that promotes EMT and invasion in ATCs. In silico analyses revealed additional factors involved in TGFb signaling as promising targets for 'antiinvasive miRs', namely, TGFBR1 and SMAD2 (Figure 3b ; Supplementary  Figures 1B and 2B) . Support for the regulation of both factors by 'antiinvasive miRs' was provided by the finding that SMAD2 and TGFBR1 protein levels were elevated in ATCs but remained essentially unaffected in PTCs and FTCs (Figure 3a) . Therefore, the regulation of TGFBR1 and SMAD2 expression by both miR families was validated in ATC-derived cells. The overexpression of miR-141 and miR-200a led to significantly reduced TGFBR1 and SMAD2 protein and mRNA levels (Figures 3c and d) . In contrast, TGFBR1 expression remained unaffected by the overexpression of miR-200c and miR-30d/e. SMAD2 protein and mRNA levels were significantly reduced by both microRNA families.
Bias of these analyses by secondary effects was evaluated by luciferase reporter comprising elements of the SMAD2 or TGFBR1 3 0 -untranslated regions containing in silico predicted microRNA targeting sites (Figure 3b ; Supplementary Figures 1 and 2) . For evaluating the control of reporter activity one member of each miR seed family (miR-141, -200c and -30e) was used. Transfection of miR-141 resulted in reduced luciferase activity of TGFBR1 reporters supporting regulation of TGFBR1 expression by the miR-200 family (Supplementary Figure 1C) . As observed for endogenous TGFBR1, the overexpression of miR-30e or -200c had no effect on TGFBR1 luciferase reporters. Specific regulation of reporter transcripts comprising predicted microRNA targeting sites for all analyzed antiinvasive miRs was observed for SMAD2 luciferase reporters (Supplementary Figure 2C) . Likewise, regulation of ZEB2 expression by miR-30e was confirmed by luciferase reporter analyses (Supplementary Figure 3C) . Mutational inactivation of microRNA targeting sites confirmed direct regulation of (1) TGFBR1 by miR-141; (2) SMAD2 by miR-141/200c/30e; and (3) ZEB2 by miR-30e (Supplementary Figures 1-3) . Hence, antiinvasive miRs apparently modulated TGFb signaling not only by ZEBs and TGFb but also by targeting TGFBR1 and its downstream effector SMAD2.
These findings suggested that blocking TGFBR1 could induce MET in ATC-derived cells. Therefore, cells were transfected with an TGFBR1-directed siRNA and were treated with the TGFBR1 inhibitor I (Calbiochem, Darmstadt, Germany) 48 h after transfection, as knockdown or inhibitor alone proved insufficient to block TGFBR1 (data not shown). At 4 days after transfection, this treatment resulted in significant morphological changes indicating the induction of MET (Figure 3e ). In agreement with the role of ZEBs as key modulators of EMT/MET, ZEB1/2 expression was reduced by interfering with TGFBR1-mediated signaling (Figures 3f and g ). The induction of MET was further confirmed by decreased vimentin levels, whereas an increase in E-cadherin expression was only observed on the mRNA level. TGFBR1 inhibition also reduced SMAD2 mRNA and protein levels. On the microRNA level, combined knockdown or inhibition of TGFBR1 was correlated with increased abundance of the miR-200 family, whereas levels of the miR-30 family remained (Invitrogen, Darmstadt, Germany) . Reverse transcription was performed by using miR-specific oligonucleotides supplied with TaqMan probes. The relative amount of each microRNA was determined by cross-normalization to NT samples using the DDC t method and U18 as an internal reference. Indicated by dashed lines, statistical significance was determined by pair-wise Student's t-testing: *Pp0.05; ** Pp0.005; ***Pp0.0005. Note that changes in miR abundance are shown in logarithmic scale in (a) and (b).
Downregulation of microRNAs
J Braun et al largely unaffected (Figure 3h ). In contrast, we observed a significant reduction of the proinvasive miR-21. The latter was shown to promote metastasis and invasion of metastatic breast cancer cells (Zhu et al., 2008) . Notably, the expression of miR-21 was elevated approximately threefold in primary ATC samples (Table 1 ) and recent evidence indicated that TGFb signaling by SMAD2 promotes miR-21 maturation (Davis et al., 2008) . Hence, TGFb signaling apparently modulates the invasiveness of tumor cells by the downregulation as well as upregulation of specific miRs. The aforementioned observations raised the question whether the observed changes in gene expression in response to blocking TGFBR1 were modulated exclusively by the downregulation of ZEB proteins. This hypothesis was evaluated by ZEB1/2 knockdown in ATC-derived cells resulting in increased expression of E-cadherin and the miR-200a, -200b and -429 cluster (Supplementary Figures 4A-C) . However, miR-141, miR-200c, vimentin, SMAD2 and TGFBR1 levels seemed to be unaffected. In consensus with these moderate effects on gene expression, morphological changes were insignificant (Supplementary Figure 4D) . Although these findings could be due to insufficient ZEB1/2 knockdown, we propose that these observations indicate the involvement of ZEB-independent factors Table 3 ) 72 h after transfection of the indicated miR pools. Cells were lysed in RIPA buffer and total protein concentration of lysates was determined by D C protein assay (Bio-Rad, Mu¨nchen, Germany) to allow equal loading. Vinculin and b-actin served as loading controls. Blots were analyzed by infrared scanning using an Odyssey scanner (Licor, Bad Homburg, Germany). (c) Changes in mRNA abundance were analyzed by quantitative RT-PCR 72 h after transfection of the indicated miR-pools. Relative mRNA levels were determined by the DDC t method using peptidylprolyl isomerase A, RPLP0 and vinculin for internal cross-normalization using the indicated primers (Supplementary Table 3 Figure 5) . Support for this assumption was provided by the inhibition of TGFBR1 resulting in elevated levels of the miR-200 family but decreased amounts of vimentin.
In conclusion, our studies showed that the altered expression of pro-and antiinvasive microRNAs correlates with EMT and the invasive potential of ATCs. Downregulation of antiinvasive miR-200 and miR-30 families distinguishes ATCs from other thyroid carcinomas of follicular origin and induces severe changes in gene expression. These apparently 'merge' on TGFb signaling and thus indicate that deregulation of TGFb signaling is a hallmark of ATCs and potentially other invasive thyroid carcinomas, as proposed for invasive PTCs (Vasko et al., 2007) . In agreement with previous studies, we show that TGFb-dependent control of EMT/ MET in ATCs essentially involves feedback regulation of ZEBs and the miR-200 family Park et al., 2008) . However, our findings also identify another were analyzed in cells treated as described in (e) by using the indicated TaqMan probes. Relative miRNA levels were determined as described in Figure 1 .
J Braun et al class of 'antiinvasive' miRs, the miR-30 family. This modulates TGFb-controlled EMT/MET and invasion of ATC-derived cells by controlling expression of SMAD2, ZEBs and vimentin. In contrast to the miR-200 family and miR-21, expression or maturation of the miR-30 family seems to be controlled in a TGFb-independent manner, as miR-30 levels remained unaffected by TGFBR1 inhibition. In extension to previous analyses, our results furthermore indicate that the microRNAmodulated role of TGFb signaling in directing EMT/ MET and invasion of ATCs also involves the control of TGFBR1 expression by the miR-200 family. These results are supported by previous analyses in other tumors and tumor-derived cells, in which it was shown that TGFBR1 acting through SMAD2/SMAD3 promotes metastasis and angiogenesis by modulating gene expression, for instance, the upregulation of metalloproteinase-9 and/or vascular endothelial growth factor (Cui et al., 1996; Piek et al., 1999; Guzinska-Ustymowicz and Kemona, 2005; Safina et al., 2007; Shao et al., 2009) . Notably, recent evidence indicates that altered TGFb signaling also modulates microRNA maturation by RSMADs, as shown for the proinvasive miR-21 (Davis et al., 2008) . In consensus with these findings, we observed that (1) miR-21 as well as TGFBR1 and SMAD2 levels were significantly elevated in primary ATCs and (2) interfering with TGFBR1 signaling resulted in decreased levels of SMAD2 and miR-21 in ATC-derived cells. Hence, EMT and the invasiveness of ATCs seem to be directed by altered TGFb signaling and its crosstalk with microRNA expression, which are interconnected by complex feedback regulations (Supplementary Figure 5) . Consistently, microRNA signatures as well as the resulting changes in gene expression unambiguously distinguish ATCs from other thyroid carcinomas of follicular origin. Thus, our findings provide novel markers for the identification of ATCs and suggest that TGFBR1 inhibition can provide a promising approach for the treatment of ATCs.
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